Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stages of Infection01:26

Stages of Infection

55.9K
Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
55.9K
Infection01:20

Infection

7.8K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
7.8K
Classification of Illness01:17

Classification of Illness

7.4K
The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
7.4K
T Cell Types and Functions01:24

T Cell Types and Functions

963
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
963
Viral Recombination00:57

Viral Recombination

23.3K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.3K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

11.5K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Racial identity, marginalization, and depression in pediatric-onset multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Phase 2 Futility Trials in Alzheimer Disease and Mild Cognitive Impairment: A Cohort Analysis of the ADNI Data Set.

Neurology·2026
Same author

Application of the 2024 McDonald Criteria in Individuals With Nonspecific Symptoms or Incidental Imaging Findings in a Multicenter Study.

Neurology·2026
Same author

Impact of depression and anxiety on health-related quality of life changes over time within individuals with rheumatoid arthritis or inflammatory bowel disease: A prospective Canadian cohort study.

PloS one·2026
Same author

Prescription drug dispensations 15 years before multiple sclerosis onset: A matched cohort study, British Columbia, Canada.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Phenotyping healthcare use before pediatric-onset multiple sclerosis, including by sex and age: A matched cohort study.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Related Experiment Video

Updated: Jun 15, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K

Infection, Relapses, and Pseudo-Relapses in Individuals With Multiple Sclerosis.

Amber Salter1,2, Samantha Lancia1, Mudita Sharma1

  • 1Department of Neurology, Section on Statistical Planning and Analysis, University of Texas Southwestern, Dallas.

Neurology. Clinical Practice
|June 13, 2025
PubMed
Summary
This summary is machine-generated.

Infections in multiple sclerosis (MS) patients increase relapse risk, with non-COVID infections raising it by 39%. COVID-19 infections, however, showed a decreased relapse likelihood. All infections significantly raised pseudo-relapse risk.

More Related Videos

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

4.7K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

57.9K

Related Experiment Videos

Last Updated: Jun 15, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

4.7K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

57.9K

Area of Science:

  • Neurology
  • Infectious Diseases
  • Immunology

Background:

  • Infections are known to increase relapse and pseudo-relapse risk in multiple sclerosis (MS).
  • The specific impact of SARS-CoV-2 (COVID-19) infections versus other infections on MS relapses is not well understood.
  • Understanding these associations is crucial for managing MS patients, who are more susceptible to infections.

Purpose of the Study:

  • To compare the occurrence of relapse and pseudo-relapse following COVID-19 infections versus other infections in individuals with MS.
  • To analyze the relationship between different types of recent infections and subsequent neurological events in MS.

Main Methods:

  • A survey was conducted in spring 2023 among participants in the North American Research Committee on Multiple Sclerosis Registry.
  • Participants were categorized based on recent infections (COVID-19, non-COVID, both, or none) within the prior 6 months.
  • Statistical analysis compared relapse and pseudo-relapse rates across infection groups, adjusting for covariates.

Main Results:

  • Non-COVID infections increased relapse likelihood by 39% (OR 1.39), while COVID-19 infections decreased it (OR 0.45).
  • All infection groups showed significantly increased odds of pseudo-relapse compared to uninfected individuals (ORs ranging from 1.78 to 3.04).
  • Out of 2,927 participants, 10% had recent COVID-19, 29.1% had non-COVID infections, 8.4% had both, and 52.4% were uninfected.

Conclusions:

  • Infections, regardless of type, are associated with a higher risk of pseudo-relapse in MS patients.
  • While non-COVID infections elevate relapse risk, COVID-19 may decrease it, warranting further investigation.
  • Clinical management of MS should consider the heightened risk of acute worsening following any infection.